- This will be a year that will fall under the banner of Poland's presidency of the Council of the European Union. Our department will also be focused on these aspects in the first half of the year. We have great potential in new technologies - there are about 90 proceedings underway. We are also finishing the preparation of an amendment to the Reimbursement Law. This law has always stirred up emotions. So this year will be demanding," Mateusz Oczkowski, deputy director of the Drug Policy and Pharmacy Department at the Health Ministry, said in an interview with Medexpress.
The year 2024 is coming to an end. How can you sum it up from a drug policy perspective?
The year 2024 for the Department of Drug Policy and Pharmacy, as well as for the Ministry of Health as a whole, was a special year. On the one hand, our pace of work on making drug technologies available did not slow down, and in fact maintained a similar level. We had 135 new technologies introduced for reimbursement, of which 100 were for non-oncology indications and 36 for oncology indications. Among them, we...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
